BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
4/12/2024 4:45:44 PM | Browse: 24 | Download: 21
2
Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
3/27/2024 1:28:19 PM | Browse: 32 | Download: 113
3
Metabolic disease and the liver: A review
1/23/2024 9:31:45 AM | Browse: 63 | Download: 110
4
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
12/27/2023 5:42:53 AM | Browse: 48 | Download: 153
5
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
12/6/2023 8:08:49 AM | Browse: 90 | Download: 208
6
Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
8/18/2023 10:08:22 AM | Browse: 111 | Download: 388
7
Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
6/25/2023 2:17:08 PM | Browse: 110 | Download: 277
8
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 118 | Download: 316
9
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
3/22/2023 11:20:34 AM | Browse: 128 | Download: 395
10
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
2/24/2023 1:35:50 PM | Browse: 161 | Download: 399
11
Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
2/24/2023 1:35:50 PM | Browse: 158 | Download: 401
12
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
1/6/2023 2:52:58 AM | Browse: 169 | Download: 353
13
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
1/4/2023 5:53:01 AM | Browse: 170 | Download: 379
14
Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
11/16/2022 11:26:06 AM | Browse: 242 | Download: 446
15
Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease
10/28/2022 7:46:25 AM | Browse: 262 | Download: 617
16
Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
9/27/2022 1:00:18 PM | Browse: 190 | Download: 561
17
Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study
9/23/2022 12:48:56 AM | Browse: 257 | Download: 670
18
Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
9/15/2022 1:37:25 PM | Browse: 259 | Download: 542
19
Nonalcoholic fatty liver disease and diabetes
9/9/2022 3:45:24 PM | Browse: 324 | Download: 661
20
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM | Browse: 219 | Download: 633
21
Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
7/27/2022 1:17:37 PM | Browse: 273 | Download: 519
22
Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease
7/27/2022 1:17:37 PM | Browse: 272 | Download: 623
23
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
7/18/2022 9:47:46 AM | Browse: 330 | Download: 626
24
Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
7/18/2022 9:47:46 AM | Browse: 364 | Download: 904
25
Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases
7/13/2022 7:31:00 AM | Browse: 239 | Download: 548
26
Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
7/4/2022 12:30:52 PM | Browse: 311 | Download: 1126
27
Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
6/23/2022 2:39:01 PM | Browse: 272 | Download: 636
28
Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in children: A case report
6/17/2022 3:19:27 AM | Browse: 261 | Download: 593
29
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
5/24/2022 10:35:19 AM | Browse: 341 | Download: 681
30
Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
5/18/2022 11:24:37 AM | Browse: 308 | Download: 684
31
Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
5/10/2022 9:43:36 AM | Browse: 330 | Download: 699
32
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
4/30/2022 5:08:22 AM | Browse: 304 | Download: 718
33
Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice
4/29/2022 6:42:52 AM | Browse: 365 | Download: 1222
34
Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
4/22/2022 10:52:23 AM | Browse: 312 | Download: 611
35
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
4/15/2022 8:25:28 AM | Browse: 347 | Download: 995
36
Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
2/22/2022 9:25:37 AM | Browse: 393 | Download: 717
37
Nonalcoholic fatty liver disease shows significant sex dimorphism
2/11/2022 5:55:19 AM | Browse: 289 | Download: 811
38
Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
2/9/2022 7:25:27 AM | Browse: 324 | Download: 595
39
Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
12/27/2021 5:24:01 AM | Browse: 381 | Download: 779
40
Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia
12/27/2021 5:24:01 AM | Browse: 387 | Download: 879
41
Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
11/24/2021 9:54:22 AM | Browse: 456 | Download: 741
42
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
11/24/2021 9:54:22 AM | Browse: 354 | Download: 782
43
Screening for nonalcoholic fatty liver disease-when, who and how?
9/15/2021 10:33:58 AM | Browse: 463 | Download: 816
44
Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
9/7/2021 8:15:21 AM | Browse: 446 | Download: 707
45
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 514 | Download: 1010
46
Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
8/5/2021 2:37:04 PM | Browse: 385 | Download: 880
47
Racial differences in prevalence and severity of non-alcoholic fatty liver disease
7/23/2021 8:10:13 AM | Browse: 420 | Download: 623
48
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
7/12/2021 12:42:13 AM | Browse: 459 | Download: 926
49
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 395 | Download: 972
50
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea
6/24/2021 7:26:32 AM | Browse: 359 | Download: 1078
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345